Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
572816
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
||
|
FDA ORPHAN DRUG |
572716
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1879918-31-6
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
C125549
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
FG-29
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
7K5O7P6QIU
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
7K5O7P6QIU
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
Loncastuximab tesirine
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
100000181778
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
2540964
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY | |||
|
10586
Created by
admin on Tue Apr 01 21:08:38 GMT 2025 , Edited by admin on Tue Apr 01 21:08:38 GMT 2025
|
PRIMARY |
ACTIVE MOIETY